Free Trial

EP Wealth Advisors LLC Purchases New Shares in Globe Life Inc. $GL

Globe Life logo with Finance background

EP Wealth Advisors LLC acquired a new position in shares of Globe Life Inc. (NYSE:GL - Free Report) in the first quarter, according to the company in its most recent disclosure with the SEC. The firm acquired 2,055 shares of the company's stock, valued at approximately $271,000.

Other hedge funds have also recently made changes to their positions in the company. SouthState Corp purchased a new position in shares of Globe Life during the 1st quarter worth approximately $43,000. SVB Wealth LLC purchased a new position in shares of Globe Life during the 1st quarter worth approximately $63,000. Allworth Financial LP boosted its position in shares of Globe Life by 22.0% during the 1st quarter. Allworth Financial LP now owns 571 shares of the company's stock worth $71,000 after purchasing an additional 103 shares during the period. Versant Capital Management Inc boosted its position in shares of Globe Life by 140.2% during the 1st quarter. Versant Capital Management Inc now owns 586 shares of the company's stock worth $77,000 after purchasing an additional 342 shares during the period. Finally, Brooklyn Investment Group boosted its position in shares of Globe Life by 792.7% during the 1st quarter. Brooklyn Investment Group now owns 732 shares of the company's stock worth $96,000 after purchasing an additional 650 shares during the period. Hedge funds and other institutional investors own 81.61% of the company's stock.

Globe Life Stock Performance

Globe Life stock traded down $0.24 during midday trading on Friday, hitting $142.25. 400,575 shares of the company's stock were exchanged, compared to its average volume of 440,235. Globe Life Inc. has a 12-month low of $100.27 and a 12-month high of $144.00. The company has a debt-to-equity ratio of 0.43, a quick ratio of 0.06 and a current ratio of 0.06. The stock has a market cap of $11.52 billion, a price-to-earnings ratio of 11.37 and a beta of 0.56. The firm's 50 day simple moving average is $134.42 and its 200 day simple moving average is $126.74.

Globe Life (NYSE:GL - Get Free Report) last issued its quarterly earnings data on Wednesday, July 23rd. The company reported $3.27 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.25 by $0.02. The company had revenue of $1.48 billion for the quarter, compared to the consensus estimate of $1.50 billion. Globe Life had a net margin of 18.11% and a return on equity of 21.24%. Globe Life's revenue for the quarter was up 2.9% on a year-over-year basis. During the same period last year, the firm posted $2.97 EPS. Globe Life has set its FY 2025 guidance at 14.250-14.650 EPS. Equities research analysts predict that Globe Life Inc. will post 13.87 EPS for the current year.

Globe Life Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Investors of record on Friday, October 3rd will be issued a dividend of $0.27 per share. The ex-dividend date of this dividend is Friday, October 3rd. This represents a $1.08 dividend on an annualized basis and a yield of 0.8%. Globe Life's payout ratio is currently 8.63%.

Analysts Set New Price Targets

GL has been the topic of a number of research reports. Morgan Stanley increased their target price on shares of Globe Life from $166.00 to $171.00 and gave the stock an "overweight" rating in a report on Monday, August 18th. Truist Financial initiated coverage on shares of Globe Life in a report on Tuesday, July 15th. They set a "buy" rating and a $150.00 target price on the stock. Wells Fargo & Company increased their target price on shares of Globe Life from $144.00 to $150.00 and gave the stock an "overweight" rating in a report on Friday, July 25th. Cfra Research upgraded shares of Globe Life to a "moderate buy" rating in a report on Friday, July 25th. Finally, Wall Street Zen upgraded shares of Globe Life from a "hold" rating to a "buy" rating in a report on Friday, May 16th. One analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and two have given a Hold rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average target price of $152.45.

Get Our Latest Research Report on Globe Life

Insider Activity at Globe Life

In other Globe Life news, CFO Thomas Peter Kalmbach sold 28,952 shares of the company's stock in a transaction dated Tuesday, July 29th. The shares were sold at an average price of $140.97, for a total value of $4,081,363.44. Following the sale, the chief financial officer owned 30,665 shares of the company's stock, valued at $4,322,845.05. This represents a 48.56% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Michael Clay Majors sold 10,000 shares of the company's stock in a transaction dated Friday, August 1st. The shares were sold at an average price of $137.41, for a total transaction of $1,374,100.00. Following the completion of the sale, the executive vice president directly owned 47,066 shares in the company, valued at $6,467,339.06. This trade represents a 17.52% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 84,722 shares of company stock worth $11,733,793 in the last ninety days. Corporate insiders own 1.51% of the company's stock.

About Globe Life

(Free Report)

Globe Life Inc, through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates in four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments.

Featured Articles

Institutional Ownership by Quarter for Globe Life (NYSE:GL)

Should You Invest $1,000 in Globe Life Right Now?

Before you consider Globe Life, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Globe Life wasn't on the list.

While Globe Life currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report
Like this article? Share it with a colleague.